Research
L-arginine for Bladder Health: Evidence, Interactions and Cautions
L-arginine is an ingredient used in bladder supplements marketed to women. Below is what it has actually been studied for, how strong that evidence is, the drug interactions and cautions on record, and the primary source our grade rests on — all drawn from the HerWellReport ingredient dataset.
Also sold as: Arginine; L-arginine hydrochloride
What the evidence says about L-arginine
This is one of the few bladder supplements that has actually been put through randomised placebo-controlled trials, and it failed them. The EAU chronic pelvic pain guideline states that after oral L-arginine no symptomatic relief or change in nitric oxide production could be shown. A 2016 International Urogynecology Journal systematic review of complementary therapies for bladder pain syndrome reports that the Korting randomised trial found no differences between groups on intention-to-treat analysis. The honest reading is not that the evidence is missing but that it is negative.
The grade "limited" means: limited — One or two small human trials, or trials for a closely related outcome. Grades are explained in full on our methodology page.
Read the primary source this grade rests on (opens in a new tab).
L-arginine drug interactions
- Antihypertensive drugs (arginine is a vasodilator and can add to their blood-pressure-lowering effect)
Who should be careful with L-arginine
- May increase mortality risk in people who have had an acute myocardial infarction
- long-term use may worsen peripheral artery disease
- commonly causes abdominal pain, bloating, nausea and diarrhoea
- case reports of oesophagitis and of acute pancreatitis
Read more on HerWellReport
This entry is generated from row "L-arginine" of the HerWellReport ingredient dataset (v2.1, updated 2026-09-23). The dataset is free to reuse under CC BY 4.0 — how to cite it. Ingredient evidence is not evidence for any finished product, and nothing here is medical advice.